Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
20
# OF OVERLAPPING
HOLDINGS
BBP
65
HOLDINGS
33%
ALSO IN WDNA
WDNA
90
HOLDINGS
24%
ALSO IN BBP
SECTOR DRIFT (BBP minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.1% | 1.9% | 1.9% |
|
BRIDGEBIO PHARMA, INC. | 1.9% | 2.4% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 1.8% | 1.7% |
|
AMGEN INC | 2.0% | 1.7% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 1.6% | 1.6% |
BBP Overweight Relative to WDNA
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
|
ASCENDIS PHARMA A/S | 1.8% |
|
PTC THERAPEUTICS INC | 1.8% |
BBP Underweight Relative to WDNA
|
NATERA INC | -3.7% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
VERICEL CORPORATION | -2.6% |
|
VERACYTE INC | -2.1% |
 |
NOVARTIS AG | -1.7% |
|
LABCORP HOLDINGS | -1.5% |
|
BRISTOL-MYERS SQUIBB CO | -1.5% |
|
DUPONT DE NEMOURS INC | -1.5% |